Bupropion Hydrochloride marketed by Lupin Pharmaceuticals, Inc. under NDC Code 68180-319-09
NDC Code(s) : 68180-319-06, 68180-319-09, 68180-319-02, 68180-320-06, 68180-320-09, 68180-320-02
Packager : Lupin Pharmaceuticals, Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Bupropion Hydrochloride
Bupropion Hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
Bupropion Hydrochloride
Bupropion Hydrochloride TABLET, EXTENDED RELEASE |
|
|
|
|
|
|
PRINCIPAL DISPLAY PANEL
NDC 68180-319-06
Bupropion Hydrochloride Extended-release Tablets USP (XL)
150 mg
Rx only
Bottle of 30 Tablets
![150 mg](/xml/1af14d2e-c64d-44b7-a402-8869e8e30661/892e560b-2014-4a1f-8c76-fe16285bf48f-02.jpg)
NDC 68180-320-06
Bupropion Hydrochloride Extended-release Tablets USP (XL)
300 mg
Rx only
Bottle of 30 Tablets
![150 mg](/xml/1af14d2e-c64d-44b7-a402-8869e8e30661/892e560b-2014-4a1f-8c76-fe16285bf48f-03.jpg)
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.